Clinical Evaluation of the Residual Antimicrobial Activity
NCT04495920
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Bacterial Overgrowth
Interventions
DRUG:
CGB-S-100
Sponsor
CAGE Bio Inc.
Collaborators
[object Object]